FEATURES OF BACTERIAL IMMUNOMODULATORS INFLUENCE ON IMMUNOREGULATORY MECHANISMS IN PATIENTS WITH RESPIRATORY ALLERGIES



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Recovering from bacterial infections in the first years of life reduces further risk of allergic diseases. Effects of bacterial immunomodulator Broncho Vaxom on immune system to certain extent repeats the immune response that occurs during penetration of the pathogen in the body. Bacterial antigens orchestrate cellular and humoral immune responses, stimulate innate immunity, normalize cytokine balance, and are promising in the treatment of respiratory allergic diseases.

Full Text

Restricted Access

About the authors

A V Sobolev

North-Western State Medical University named after I.I. Mechnikov

Email: isobolev757@rambler.ru
Kashkin Research Institute of Medical Mycology St. Petersburg, Russia

O V Aak

North-Western State Medical University named after I.I. Mechnikov

Kashkin Research Institute of Medical Mycology St. Petersburg, Russia

References

  1. Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008, v. 63, p. 8-160.
  2. Papadopoulos N.G., Agache I., Bavbek S. et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin. Translational Allergy. 2012, v. 2, 23 p.
  3. Sharpe R.A., Bearman N., Thornton C.R. et al. Indoor fungal diversity and asthma: A meta-analysis and systematic review of risk factors. J. Allergy Clin.Immunol. 2014, doi: 10.1016/j. jaci.2014.07.002.
  4. Соболев А.В., Аак О.В. Клиника, диагностика и лечение микогенной аллергии. Проблемы медицинской микологии. 2012, № 1, с. 37-40.
  5. Аак О.В., Фролова Е.В., Учеваткина А.Е. и соавт. Микогенная сенсибилизация и степень тяжести атопического дерматита. Проблемы медицинской микологии. 2013, № 3, с. 10-13.
  6. Strachan D.P. Hay fever, hygiene, and household size. B.M.J. 1989, v. 18, p. 1259-1260.
  7. Strachan D.P. Family size, infection and atopy: the first decade of the «hygiene hypothesis». Thorax. 2000, v. 55, р. 2-10.
  8. Mallia P., Johnston S.L. Respiratory viruses: do they protect from or induce asthma? Allergy. 2002, v. 57, p. 1118-1129.
  9. Asher M.I., Stephen Montefort, Bengt Bjorkst et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006, v. 368, p. 733-743.
  10. Renz H., Herz U. The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur.Respir. J. 2002, v. 19, p. 158-171.
  11. Bona C. Neonatal immunity. Totowa, NJ, Humana Press. 2005, 389 p.
  12. Hopfenspirger M.T., Agrawal D.K. Airway Hyperresponsiveness, Late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J. Immunol. 2002, v. 168, p. 2516-2522.
  13. Arnoldussen D.L., Linehan M., Sheikh A., BCG vaccination and allergy: A systematic review and meta-analysis. J. Allergy Clin. Immunol. 2011, v. 127, p. 246-253.
  14. Guilbert T.W., Denlinger L.C. Role of infection in the development and exacerbation of asthma. Expert Rev. Resp. Med. 2010, v. 4, p. 71-83.
  15. Воробьева О.В., Гущин И.С. Исторические предпосылки создания метода аллергенспецифической иммунотерапии (К 100-летию открытия). Рос. Аллергол. Журн. 2010, № 5, с. 17-28.
  16. Frankland A.W., Hughes W.H., Gorrill R.H. Autogenous bacterial vaccines in treatment of asthma. B.M.J. 1955, v. 2, p.941-944.
  17. Vaccine therapy in asthma (Leading article). B.M.J. 1966, v. 1, p. 186-187.
  18. Berche P., Veron M., Tinelli R. An acellular vaccine from «Pseudomonas aeruginosa». I. Preparation and activity (author’s transl). Ann. Microbiol. (Paris). 1976, v. 127, p. 247-259.
  19. Golebiowski T.E., Tinelli R.L. Protective action on mice of acellular extracts from Salmonella typhimurium. C.R. Acad. Sci. Hebd. Seances Acad. Sci. D. 1978, v. 286, p. 1633-1635.
  20. Villa E., Garelli V., Braido F. et al. May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ. J. 2010, v. 3, р. 17-23.
  21. Bauer J.A., Salvagni M., Vigroox J.P.L. et al. Bacterial extract for respiratory disorders and process for its preparation. Patent USA 8697154, 2014.
  22. Alyanakian M.A., Grela F., Aumeunier A. et al. Bach J-F. Transforming growth factor-β and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes. 2006, v. 55, p.179-185.
  23. Fontanges R., Bottex C., Cristau B., Burckhart M.F. Influence of a bacterial extract on antigen presentation and protection against experimental infections. Lung. 1990, v. 168, p. 716-719.
  24. Bessler W.G. The bacterial extract Broncho-Vaxom protects against respiratory infections - in vivo and in vitro studies. In «Microbial pathogens and strategies for combating them: science, technology and education» Badajoz (Spain): Formatex Research Center. 2013, v. 3, p. 1934-1940.
  25. Puigdollers J.M., Serna G.R., Hernandez del Rey I. et al. Immunoglobulin production in man stimulated by an orally administered bacterial lysate. Respiration. 1980, v. 40, p. 142-149.
  26. Schaad U.B. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J. Pediatr. 2010, v. 6, p. 5-12.
  27. Weinberger M. Can we prevent exacerbations ofasthma caused by common cold viruses? J. Allergy Clin. Immunol. 2010, v. 126, p. 770-771.
  28. Podleski W.K. Immunomodulation of allergic autocytotoxicity in bronchial asthma by a bacterial lysate - Broncho-Vaxom. Int. J. Immunopharmacol. 1985, v. 7, p. 713-718.
  29. Rozy A., Chorostowska-Wynimko J. Bacterial immunostimulants - mechanism of action and clinical application in respiratory diseases. Pneumonol. Alergol. Pol. 2008, v. 76, p. 353-359.
  30. Luan H., Zhang Q., Wang L. et al. OM85-BV induced the productions of IL-1ß, IL-6, and TNFa via TLR4- and TLR2-mediated ERK1/2/NF-kB pathway in RAW264.7 cells. J. Interferon Cytokine Res. 2014, v. 34, p. 526-536.
  31. Navarro S., Cossalter G., Chiavaroli C. et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T-cells to the airways. Mucosal Immunology. 2011, v. 4, p. 53-65.
  32. Byl B., Libin M., Gérard M. et al. Bacterial extract OM85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T-cells. J. Interferon Cytokine Res. 1998, v. 18, p. 817-821.
  33. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am. J. Rhinol. Allergy. 2014, v. 28, p. 110-116.
  34. Gambillara E., Wassenberg J., Audran R. et al. Effect of oral BroncoVaxom on nasal challenge with grass pollen in patients with allergic rhinitis. SSAI Conf., Geneva, 2009.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2014



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies